STROKOG

CHeBA Consortia - STROKOG
STROKOG is a consortium of post-stroke/TIA or high vascular risk studies from around the world. Originally established in 2016, it was the first international effort to harmonise work on post-stroke dementia

About STROKOG

STROKOG is a consortium of post-stroke/TIA or high vascular risk studies from around the world. STROKOG aims to harmonise data across our international member studies; to conduct joint analyses that explore questions in relation to vascular cognitive impairment and dementia (VCID), which represent a major health care burden on our society with projections to grow in the future.

STROKOG aims to increase awareness of cognitive deficits in relation to stroke and other cerebrovascular disease. We anticipate that the findings of STROKOG will help guide and optimize preventative strategies and health policy, both in Australia and internationally.

The consortium is expanding from 2022 to include, in addition to studies with stroke/TIA patients, studies with high vascular risk patients or intervention studies that aim to reduce the impact of cerebrovascular disease. See here for our membership criteria. STROKOG currently includes 38 studies from 18 countries and 5 continents. We encourage qualified researchers to propose research projects using STROKOG data. Please refer to the research proposals page for more information.

Contacts

Perminder Sachdev: p.sachdev@unsw.edu.au
Co-Director, CHeBA (Centre for Healthy Brain Ageing)
UNSW Medicine
    
Jessica Lo: jessica.lo@unsw.edu.au
Postdoc Fellow, CHeBA (Centre for Healthy Brain Ageing)
UNSW Medicine